Bristol-Myers Agrees to Acquire ZymoGenetics for $885 Million
Tuesday, September 7, 2010 - 19:56
in Mathematics & Economics
The two companies agreed in January to jointly develop ZymoGenetics’s hepatitis C drug and share the profits.